Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis. / Filikci, Zuhal; Jensen, Rikke Marie; Thorup Sellebjerg, Finn.
In: BMJ Case Reports, Vol. 15, No. 11, e250425, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis
AU - Filikci, Zuhal
AU - Jensen, Rikke Marie
AU - Thorup Sellebjerg, Finn
N1 - Publisher Copyright: © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022
Y1 - 2022
N2 - We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.
AB - We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.
KW - Multiple sclerosis
KW - Neurology
U2 - 10.1136/bcr-2022-250425
DO - 10.1136/bcr-2022-250425
M3 - Journal article
C2 - 36414352
AN - SCOPUS:85142515164
VL - 15
JO - BMJ Case Reports
JF - BMJ Case Reports
SN - 1757-790X
IS - 11
M1 - e250425
ER -
ID: 329305424